Loading
Floy
Floy develops AI-driven software that supports radiologists in detecting complex and hard-to-identify diseases. The collaboration of Floy-AI and radiologists ensures optimal patient outcomes by enabling the early detection and thus early treatment of diseases. One of Floy’s distinguishing features is our innovative incentive structure. We partner with radiology offices to jointly offer patients our AI as a “second opinion”. This unique approach motivates radiologists to embrace Floy-AI and encourages widespread adoption. Since its establishment in 2021, Floy secured €8.8 million in funding and rapidly expanded its presence with over 150 radiology locations to date. Floy’s overarching mission is to pioneer proactive medicine by providing exceptional AI-powered diagnostic experiences for health-conscious patients.
Funding
Every round, secondary, debt facility or acquisition involving Floy that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—